National Assembly to question on bioequivalency tests.

The Health and Welfare Committee of the National Assembly pointed out in the KFDA report meeting on April 19 that too many drugs proven of its bioequivalency tests flowed out within a short period of time, raising concerns and suspicions of its incomplete jobs at the relevant test institutes and test workers.

Rep. Jeong Hyeong-geun raised a question whether the completion of the bioequivalen...